On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini. This instrumentation change is necessary as Bio-Rad is discontinuing service on our existing QuickStep instrumentation.
Although the Immucor assay and sample requirements will remain the same, the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list will be available on the CTS website on 04/29/19.
The Q & A document from the Reentry Changes Webinar hosted on 06/06/18 has been posted in the Wh...
We received an updated WNV package insert; please note the manufacturer and license number has been ...
We sincerely hope to see you at this year’s AABB Annual Meeting in San Antonio, TX on October ...
Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...
The revised CTS algorithm associated with the Ortho platform is now available for review. Clie...